NDSN
NASDAQ · USDOne year, rebased to 100
NDSN SPY XLI (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universeFlags
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.Key financials · FY2025
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Valuation
NDSN vs industry median
328 companies in Industrial - MachineryEarnings delivery
Next report 2026-12-09 · consensus EPS $3.46Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| NDSN Nordson Corporation | $18.0B | 32.5x | 17.6% | 18.6% | +3.8% | +39.4% |
| ITT ITT Inc. | $17.7B | 38.8x | 11.5% | 5.8% | +28.1% | +16.3% |
| IEX IDEX Corporation | $17.4B | 33.8x | 13.0% | 15.6% | +7.3% | +44.7% |
| GGG Graco Inc. | $13.3B | 25.4x | 21.2% | 24.5% | +4.6% | +1.9% |
| XYL Xylem Inc. | $24.3B | 24.8x | 9.4% | 11.3% | +4.5% | −27.9% |
| LII Lennox International Inc. | $12.4B | 16.1x | 70.5% | 17.4% | −2.1% | — |
| DOV Dover Corporation | $26.4B | 23.4x | 15.0% | 14.3% | +7.6% | — |
| WTS Watts Water Technologies, In | $11.9B | 31.1x | 18.8% | 15.5% | +17.1% | — |
Recent 8-K filings
Context
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Narrow).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where NDSN sits among 62 scored companies in Industrial - Machinery (0 = lowest value, 100 = highest). It is a position, not a grade.Valuation
| Measure | NDSN | Industry percentile |
|---|---|---|
| P/E (TTM) | 32.3x | 65th |
| PEG (P/E ÷ 3-yr EPS CAGR) | 7.35 | 83rd |
| Price / sales | 6.0x | 98th |
| Price / book | 5.5x | 78th |
| Price / tangible book | — | |
| Price / free cash flow | 24.6x | 59th |
| Price / operating cash flow | 23.1x | 74th |
| Enterprise value | $19.7B | 75th |
| EV / sales | 6.6x | 98th |
| EV / EBITDA | 20.7x | 77th |
| EV / EBIT | 24.6x | 67th |
| EV / free cash flow | 27.0x | 52nd |
| Earnings yield | 3.1% | 43rd |
| FCF yield | 4.1% | 46th |
| Operating cash flow yield | 4.3% | 30th |
| Graham number (per share) | $114.06 | 87th |
Profitability (TTM)
| Measure | NDSN | Industry percentile |
|---|---|---|
| Gross margin | 55.3% | 100th |
| EBITDA margin | 31.8% | 98th |
| Operating margin | 26.9% | 98th |
| EBIT margin | 26.8% | 97th |
| Net margin | 18.6% | 95th |
| NOPAT margin | 22.1% | 98th |
| FCF margin | 24.4% | 93rd |
| Operating cash flow margin | 26.1% | 93rd |
| R&D / revenue | 0.0% | 0th |
| SG&A / revenue | 28.4% | 95th |
| Stock comp / revenue | 0.4% | 22nd |
| Effective tax rate | 17.7% | 20th |
Returns on capital
| Measure | NDSN | Industry percentile |
|---|---|---|
| ROE (on average equity) | 17.8% | 71st |
| ROA | 9.3% | 69th |
| ROIC | 13.3% | 64th |
| ROCE | 15.3% | 74th |
| Return on tangible assets | 13.4% | 77th |
| Cash ROIC (OCF / invested capital) | 15.7% | 63rd |
| Gross profitability (GP / assets) | 27.7% | 69th |
| ROIC, 3-yr average | 10.5% | 58th |
| ROIC, 5-yr average | 13.4% | 58th |
| ROE, 5-yr average | 18.0% | 69th |
| Incremental ROIC | -152.2% | 15th |
Growth
| Measure | NDSN | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | 7.0% | 47th |
| Revenue growth (QoQ) | 10.4% | 56th |
| Revenue CAGR, 3 yr | 4.7% | 66th |
| Revenue CAGR, 5 yr | 5.1% | 44th |
| Gross profit CAGR, 3 yr | 5.5% | 49th |
| Operating income CAGR, 3 yr | 6.4% | 47th |
| Net income growth (TTM YoY) | 22.0% | 73rd |
| Net income CAGR, 3 yr | 3.5% | 49th |
| EPS growth (TTM YoY) | 24.2% | 76th |
| EPS CAGR, 3 yr | 4.4% | 51st |
| EPS CAGR, 5 yr | 9.9% | 59th |
| FCF growth (TTM YoY) | 34.2% | 81st |
| FCF CAGR, 3 yr | 5.8% | 23rd |
| Operating cash flow CAGR, 3 yr | 6.1% | 26th |
| Book value CAGR, 3 yr | 9.2% | 54th |
| Dividend CAGR, 3 yr | 2.0% | 48th |
| Sustainable growth rate | 11.9% | 61st |
Margin history & stability
| Measure | NDSN | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | 55.0% | 100th |
| Operating margin, 3-yr average | 25.6% | 97th |
| Net margin, 3-yr average | 17.6% | 95th |
| FCF margin, 3-yr average | 21.8% | 98th |
| Revenue stability (0-1) | 0.98 | 95th |
| Earnings stability (0-1) | 0.52 | 62nd |
| Margin stability (0-1) | 0.99 | 97th |
Liquidity (latest quarter)
| Measure | NDSN | Industry percentile |
|---|---|---|
| Cash & short-term investments | $113.4M | 34th |
| Net cash (− = net debt) | −$1.7B | 31st |
| Working capital | $599.4M | 51st |
| Current ratio | 1.82 | 38th |
| Quick ratio | 1.18 | 49th |
| Cash ratio (cash + ST investments / current liabilities) | 0.16 | 25th |
| Defensive interval (days) | 329 days | 21st |
Leverage & solvency (latest quarter)
| Measure | NDSN | Industry percentile |
|---|---|---|
| Total debt | $1.8B | 61st |
| Debt / equity | 0.55 | 52nd |
| Net debt / equity | 0.52 | 65th |
| Debt / assets | 30.5% | 62nd |
| Debt / capital | 35.7% | 52nd |
| Debt / EBITDA | 1.91 | 46th |
| Net debt / EBITDA | 1.80 | 57th |
| Interest coverage (EBIT / interest) | 7.0x | 48th |
| Cash interest coverage | 6.8x | 38th |
| Debt payback (years of OCF) | 2.3 yrs | 41st |
| Liabilities / assets | 45.0% | 28th |
| IS credit model rating | A | |
| Implied credit spread (bps) | 150 | 54th |
Efficiency
| Measure | NDSN | Industry percentile |
|---|---|---|
| Asset turnover | 0.50 | 16th |
| Fixed asset turnover | 5.12 | 33rd |
| Inventory turnover | 2.9 | 23rd |
| Receivables turnover | 4.8 | 18th |
| Days sales outstanding | 76 days | 82nd |
| Days inventory outstanding | 127 days | 77th |
| Days payables outstanding | 39 days | 20th |
| Cash conversion cycle (days) | 164 days | 90th |
| Capex / revenue | 1.7% | 18th |
| Capex / depreciation | 0.33 | 15th |
| Operating expense ratio | 28.2% | 84th |
Cash flow & earnings quality
| Measure | NDSN | Industry percentile |
|---|---|---|
| Operating cash flow / net income | 1.40 | 47th |
| FCF / net income | 1.31 | 64th |
| FCF / operating cash flow | 93.7% | 98th |
| Capex / operating cash flow | 6.3% | 2nd |
| Accruals ratio | -3.7% | 46th |
| Sloan accruals ratio | -1.5% | 51st |
| Earnings quality score (0-1) | 1.00 | 25th |
Scores & forensic checks
| Measure | NDSN | Industry percentile |
|---|---|---|
| IS score | 75 | 95th |
| IS profitability | 71 | 90th |
| IS growth | 61 | 75th |
| IS value | 45 | 33rd |
| IS momentum | 87 | 87th |
| IS risk (safety) | 100 | 48th |
| IS quality | 87 | 97th |
| IS balance sheet | 58 | 39th |
| IS earnings quality | 71 | 36th |
| IS cash flow | 82 | 95th |
| Piotroski F-score (0-9) | 9 | 92nd |
| Altman Z-score | 5.9 | 77th |
| Beneish M-score | −2.58 | 37th |
| Ohlson O-score | −8.67 | 25th |
| IS credit score | 75 | 44th |
Size (TTM)
| Measure | NDSN | Industry percentile |
|---|---|---|
| Market cap | $18.0B | 77th |
| Revenue | $3.0B | 52nd |
| EBITDA | $947.4M | 74th |
| Net income | $555.2M | 75th |
| Free cash flow | $728.5M | 75th |
| Total assets | $5.9B | 64th |
| Shareholders' equity | $3.3B | 70th |
| Employees | 8,200 | 56th |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-14 | Morris Milton Mayo Director |
Open-market sale | 255 | $327.20 | $83,436 | 2,265 |
| 2026-09-15 | Rutledge Joseph M VP, CAO |
Open-market sale | 684 | $309.38 | $211,616 | 2,134 |
| 2026-09-02 | Morris Milton Mayo Director |
Open-market sale | 156 | $316.63 | $49,394 | 2,515 |
| 2026-09-01 | Hall Justin E EVP |
Tax withholding | 118 | $314.40 | $37,099 | 1,397 |
| 2026-08-27 | Mcdonough Jennifer L EVP, GC, and Secretary |
Open-market sale | 260 | $336.00 | $87,360 | 6,346 |
| 2026-08-26 | Hopgood Daniel Roy EVP, CFO |
Option exercise | 1,329 | $209.73 | $278,731 | 6,087 |
| 2026-08-26 | Hopgood Daniel Roy EVP, CFO |
Open-market sale | 1,329 | $334.29 | $444,271 | 4,758 |
| 2026-08-26 | Hopgood Daniel Roy EVP, CFO |
Option exercise | 1,329 | $209.73 | $278,731 | 15,695 |
| 2026-07-31 | Rutledge Joseph M VP, CAO |
Tax withholding | 274 | $297.78 | $81,592 | 2,818 |
| 2026-07-31 | Mapes Christopher L Director |
Award / grant | 42 | $297.78 | $12,507 | 3,025 |
| 2026-07-31 | Deford John A Director |
Award / grant | 84 | $297.78 | $25,014 | 5,902 |
| 2026-06-01 | Hopgood Daniel Roy EVP, CFO |
Tax withholding | 148 | $281.31 | $41,634 | 4,758 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Award / grant | Acquired | 5 | 526 | $151,483 |
| Open-market sale | Disposed | 5 | 2,684 | $876,078 |
| Option exercise | Disposed | 1 | 1,329 | $278,731 |
| Option exercise | Acquired | 1 | 1,329 | $278,731 |
| Tax withholding | Disposed | 3 | 540 | $160,325 |
Form 144 notices
12 months: 14 notices · 97,803 shares · $27.8M| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| 2026-10-14 | Morris Milton Mayo | 255 | $83,436 |
| 2026-09-02 | Morris Milton Mayo | 156 | $49,408 |
| 2026-08-27 | Mcdonough Jennifer L | 260 | $87,360 |
| 2026-08-26 | Hopgood Daniel Roy | 1,329 | $444,271 |
Congress trades
12 months: House 0 trades (0 purchases) · Senate 0 (0 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2025-04-08 | Rob Bresnahan | House | Sale (Full) | $1,001 - $15,000 | 2025-05-08 |
| 2025-04-07 | Robert P. Bresnahan | House | Sale (Full) | $1,001 - $15,000 | 2025-05-08 |
| 2025-02-25 | Rob Bresnahan | House | Sale | $1,001 - $15,000 | 2025-03-28 |
| 2025-02-24 | Robert P. Bresnahan | House | Sale (Full) | $1,001 - $15,000 | 2025-03-28 |
| 2024-05-03 | Tommy Tuberville | Senate | Sale (Full) | $1,001 - $15,000 | 2024-06-14 |
| 2024-05-03 | Tommy Tuberville | Senate | Sale (Full) | $1,001 - $15,000 | 2024-06-13 |
| 2024-05-03 | Thomas Hawley Tuberville | Senate | Sale (Full) | $1,001 - $15,000 | 2024-06-13 |
| 2023-04-03 | Tommy Tuberville | Senate | Purchase | $1,001 - $15,000 | 2023-05-12 |
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| BlackRock, Inc. | 4,138,179 | $1.2B | 7.43% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,465,215 | $1.0B | 6.22% |
| STATE STREET CORP | 2,975,009 | $899.9M | 5.34% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,360,166 | $712.0M | 4.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 1,906,425 | $573.4M | 3.42% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,713,620 | $517.0M | 3.08% |
| Invesco Ltd. | 1,318,573 | $397.8M | 2.37% |
| MORGAN STANLEY | 1,208,970 | $364.7M | 2.17% |
| FMR LLC | 840,395 | $253.5M | 1.51% |
| NORGES BANK | 715,042 | $215.7M | 1.28% |
| GOLDMAN SACHS GROUP INC | 636,339 | $192.0M | 1.14% |
| JPMORGAN CHASE & CO | 578,818 | $175.6M | 1.04% |
| ProShare Advisors LLC | 577,715 | $174.3M | 1.04% |
| AMERIPRISE FINANCIAL INC | 490,674 | $148.0M | 0.88% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 479,769 | $144.9M | 0.86% |
Institutional ownership by quarter
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 758 | 77.5% | 101 | 294 | 240 | 49 |
| 2026-03-31 | 714 | 74.0% | 92 | 249 | 255 | 58 |
| 2025-12-31 | 692 | 75.9% | 121 | 198 | 252 | 52 |
| 2025-09-30 | 633 | 75.8% | 86 | 196 | 240 | 52 |
| 2025-06-30 | 608 | 78.6% | 83 | 221 | 228 | 66 |
| 2025-03-31 | 597 | 77.0% | 68 | 235 | 215 | 66 |
| 2024-12-31 | 604 | 76.3% | 82 | 208 | 219 | 76 |
| 2024-09-30 | 607 | 75.7% | 72 | 225 | 201 | 55 |
| 2024-06-30 | 595 | 75.8% | 63 | 240 | 193 | 63 |
| 2024-03-31 | 604 | 74.5% | 75 | 233 | 187 | 52 |
| 2023-12-31 | 585 | 74.5% | 80 | 191 | 225 | 55 |
| 2023-09-30 | 568 | 75.0% | 59 | 227 | 176 | 48 |
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| 2026-03-27 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 |
| 2025-08-11 | SCHEDULE 13G | STATE STREET CORPORATION | 5.2% | 2,957,894 |
| 2025-01-02 | SCHEDULE 13G | Jennifer A. Savage | 5.2% | 2,945,523 |
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.02% | $552.8M |
| VTI | 0.02% | $552.8M |
| VTSAX | 0.02% | $552.8M |
| VSMPX | 0.02% | $552.8M |
| VFFSX | 0.03% | $455.9M |
| VFIAX | 0.03% | $455.9M |
Share structure
Income statement
Fiscal years, USD| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.6B | $2.6B | $2.7B | $2.8B |
| Cost of revenue | $1.0B | $1.2B | $1.2B | $1.2B | $1.3B |
| Gross profit | $1.3B | $1.4B | $1.4B | $1.5B | $1.5B |
| R&D | $59.4M | $52.5M | $71.4M | $65.0M | $68.2M |
| SG&A | $709.0M | $724.2M | $752.6M | $812.1M | $747.3M |
| Operating income | $615.1M | $702.4M | $672.8M | $674.0M | $724.3M |
| EBITDA | $703.5M | $771.6M | $786.7M | $810.6M | $874.8M |
| Pretax income | $574.2M | $649.3M | $615.3M | $585.5M | $597.6M |
| Income tax | $119.8M | $136.2M | $127.8M | $118.2M | $113.2M |
| Net income | $454.4M | $513.1M | $487.5M | $467.3M | $484.5M |
| EPS, diluted | $7.74 | $8.81 | $8.46 | $8.11 | $8.51 |
| Diluted shares | 58.7M | 58.2M | 57.6M | 57.6M | 56.9M |
Balance sheet
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash & short-term investments | $300.0M | $163.5M | $115.7M | $116.0M | $108.4M |
| Receivables | $489.4M | $537.3M | $590.9M | $594.7M | $587.8M |
| Inventory | $327.2M | $383.4M | $454.8M | $476.9M | $444.8M |
| Total current assets | $1.2B | $1.1B | $1.2B | $1.3B | $1.2B |
| PP&E, net | $355.6M | $353.4M | $499.0M | $638.2M | $594.4M |
| Goodwill & intangibles | $2.1B | $2.1B | $3.5B | $4.0B | $4.0B |
| Total assets | $3.8B | $3.8B | $5.3B | $6.0B | $5.9B |
| Accounts payable | $91.7M | $99.3M | $106.3M | $97.8M | $121.0M |
| Total current liabilities | $445.4M | $834.2M | $582.1M | $528.5M | $758.3M |
| Long-term debt | $781.7M | $345.3M | $1.6B | $2.1B | $1.7B |
| Total liabilities | $1.6B | $1.5B | $2.7B | $3.1B | $2.9B |
| Shareholders' equity | $2.2B | $2.3B | $2.6B | $2.9B | $3.0B |
Cash flow statement
Outflows are negative| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | $454.4M | $513.1M | $487.5M | $467.3M | $484.5M |
| Depreciation & amortization | $103.9M | $99.9M | $111.9M | $136.2M | $150.5M |
| Stock-based compensation | $22.8M | $30.7M | $22.7M | $0 | $0 |
| Change in working capital | $29.0M | −$107.3M | −$3.6M | −$53.1M | $56.8M |
| Operating cash flow | $545.9M | $513.1M | $641.3M | $556.2M | $719.2M |
| Capital expenditure | −$38.3M | −$51.4M | −$34.6M | −$64.4M | −$58.1M |
| Free cash flow | $507.6M | $461.7M | $606.7M | $491.8M | $661.1M |
| Investing cash flow | −$33.2M | −$222.8M | −$1.4B | −$844.4M | −$26.7M |
| Net debt issued / repaid | −$296.0M | −$39.3M | $969.2M | $458.2M | −$230.0M |
| Buybacks | −$61.0M | −$262.9M | −$89.7M | −$33.3M | −$306.4M |
| Dividends paid | −$97.7M | −$125.9M | −$150.4M | −$161.4M | −$179.1M |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Gross margin | 56.1% | 55.1% | 54.2% | 55.2% | 55.2% |
| Operating margin | 26.0% | 27.1% | 25.6% | 25.1% | 25.5% |
| Net margin | 19.2% | 19.8% | 18.5% | 17.4% | 17.4% |
| FCF margin | 21.5% | 17.8% | 23.1% | 18.3% | 23.7% |
| ROE | 23.2% | 23.0% | 19.9% | 16.9% | 16.2% |
| ROIC | 17.3% | 18.6% | 12.3% | 10.5% | 11.3% |
| ROA | 12.2% | 13.5% | 10.7% | 8.3% | 8.1% |
| Debt / equity | 0.44 | 0.38 | 0.72 | 0.79 | 0.71 |
| Interest coverage | 23.5x | 30.0x | 11.3x | 7.6x | 6.0x |
| Current ratio | 2.62 | 1.36 | 2.11 | 2.41 | 1.64 |
| Revenue growth | +11.4% | +9.7% | +1.5% | +2.3% | +3.8% |
| EPS growth | +81.7% | +14.8% | −4.5% | −4.2% | +5.9% |
| P/E at year end | 31.3x | 24.4x | 24.4x | 30.0x | 26.9x |
| EV / EBITDA at year end | 21.1x | 17.1x | 17.3x | 20.0x | 17.4x |
| FCF yield at year end | 3.57% | 3.70% | 5.10% | 3.51% | 5.07% |
| Dividend payout | 21.5% | 24.5% | 30.8% | 34.5% | 37.0% |
Revenue by segment
| FY2021 | FY2022 | FY2023 | FY2024 | |
|---|---|---|---|---|
| Industrial Precision Solutions | — | $1.3B | $1.4B | $1.5B |
| Adhesive Dispensing Systems | $1.2B | — | — | — |
| Advanced Technology Systems | $1.1B | $562.9M | $577.3M | $510.2M |
| Medical And Fluid Solutions | — | $690.2M | $660.3M | $695.5M |
Revenue by region · FY2024
Street estimates by fiscal year
Next report 2026-12-09 · consensus EPS $3.46 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $3.1B | $3.0B – $3.1B | $11.94 | $11.58 – $12.08 | 5 | 27.0x |
| 2027 | $3.2B | $3.2B – $3.2B | $12.97 | $12.42 – $13.22 | 5 | 24.9x |
| 2028 | $3.4B | $3.3B – $3.5B | $14.07 | $13.79 – $14.49 | 3 | 22.9x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-08-19 | $3.09 | $3.25 | +5.2% | $779.5M | $817.7M | +4.9% |
| 2026-02-18 | $2.37 | $2.37 | 0.0% | $652.8M | $669.5M | +2.6% |
| 2025-12-10 | $2.93 | $3.03 | +3.4% | $761.0M | $751.8M | −1.2% |
| 2025-08-20 | $2.64 | $2.73 | +3.4% | $723.6M | $741.5M | +2.5% |
| 2025-05-28 | $2.36 | $2.42 | +2.5% | $672.0M | $682.9M | +1.6% |
| 2025-02-19 | $2.09 | $2.06 | −1.4% | $639.6M | $615.4M | −3.8% |
| 2024-12-11 | $2.59 | $2.78 | +7.3% | $736.8M | $744.5M | +1.0% |
| 2024-08-21 | $2.33 | $2.41 | +3.4% | $657.3M | $661.6M | +0.7% |
| 2024-05-20 | $2.32 | $2.34 | +0.9% | $661.1M | $650.6M | −1.6% |
| 2024-02-21 | $2.04 | $2.21 | +8.3% | $630.4M | $633.2M | +0.4% |
| 2023-12-13 | $2.39 | $2.46 | +2.9% | $650.4M | $719.3M | +10.6% |
| 2023-08-21 | $2.32 | $2.35 | +1.3% | $707.5M | $648.7M | −8.3% |
| 2023-05-22 | $2.11 | $2.26 | +7.1% | $638.7M | $650.2M | +1.8% |
| 2023-02-20 | $1.97 | $1.95 | −1.0% | $623.9M | $610.5M | −2.1% |
| 2022-12-14 | $2.33 | $2.44 | +4.7% | $651.3M | $683.6M | +5.0% |
| 2022-08-22 | $2.44 | $2.49 | +2.0% | $650.6M | $662.1M | +1.8% |
| 2022-05-23 | $2.29 | $2.43 | +6.1% | $646.4M | $635.4M | −1.7% |
| 2022-02-22 | $1.91 | $2.07 | +8.4% | $606.9M | $609.2M | +0.4% |
| 2021-12-15 | $2.10 | $1.88 | −10.5% | $607.0M | $599.2M | −1.3% |
| 2021-08-30 | $2.08 | $2.42 | +16.3% | $555.3M | $646.9M | +16.5% |
| 2021-05-24 | $1.64 | $2.12 | +29.3% | $547.4M | $589.5M | +7.7% |
| 2021-02-22 | $1.06 | $1.32 | +24.5% | $509.9M | $526.6M | +3.3% |
| 2020-12-15 | $1.53 | $1.59 | +3.9% | $536.6M | $558.5M | +4.1% |
| 2020-08-19 | $1.34 | $1.42 | +6.0% | $511.7M | $538.2M | +5.2% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $149.6M | 470,878 | 28,387 |
| 2026-08-24 | $166.8M | 502,017 | 31,577 |
| 2026-08-17 | $306.6M | 951,607 | 46,547 |
| 2026-08-10 | $118.4M | 381,787 | 26,438 |
| 2026-08-03 | $105.0M | 340,848 | 28,144 |
| 2026-07-27 | $122.8M | 412,328 | 28,175 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 47.3% | 57,309 | 121,095 |
| 2026-10-14 | 35.1% | 32,979 | 93,943 |
| 2026-10-13 | 47.8% | 45,994 | 96,259 |
| 2026-10-12 | 44.5% | 42,073 | 94,547 |
| 2026-10-09 | 37.3% | 42,172 | 113,110 |
| 2026-10-08 | 34.6% | 50,727 | 146,796 |
| 2026-10-07 | 26.6% | 58,042 | 218,292 |
| 2026-10-06 | 30.9% | 29,718 | 96,095 |
| 2026-10-05 | 49.0% | 58,783 | 119,989 |
| 2026-10-02 | 52.5% | 55,159 | 105,014 |
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| Jan | −1.2% | 45% | 20 |
| Feb | +1.8% | 60% | 20 |
| Mar | +1.4% | 62% | 21 |
| Apr | +3.7% | 60% | 20 |
| May | +2.4% | 60% | 20 |
| Jun | +0.2% | 50% | 20 |
| Jul | +1.6% | 65% | 20 |
| Aug | −0.3% | 45% | 20 |
| Sep | +0.8% | 50% | 20 |
| Oct | +2.2% | 65% | 20 |
| Nov | +2.1% | 85% | 20 |
| Dec | +2.7% | 65% | 20 |
Indicators
as of 2026-10-16Moving averages and bands
level (price vs level)About Nordson Corporation
Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment. The Medical and Fluid Solutions segment offers precision manual and semi-automated dispensers, plastic molded syringes, cartridges, tips, and fluid connection components; interventional solutions for engineered shafts and interventional delivery systems, medical tubing, balloons, balloon inflators, nitinol devices, cardiovascular cannula, and biomaterial delivery; medical fluid components; and microplegia myocardial protection devices and related consumables. The Advanced Technology Solutions segment provides automated dispensing systems for high-speed, precise application of various attachment, protection, and coating fluids, and related gas plasma treatment systems; destructive and non-destructive testing technologies, such as bond testers and automated optical, acoustic microscopy, and x-ray inspection systems used in the semiconductor and printed circuit board industries; and precision measurement and control technologies. The company markets its products through direct sales force, distributors, and sales representatives. Nordson Corporation was founded in 1909 and is headquartered in Westlake, Ohio.
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| Sundaram Nagarajan | President, Chief Executive Officer & Director | $2.4M | 1963 |
| Joseph Kelley | Executive Vice President of Industrial Precision Solutions Leader | $1.0M | 1973 |
| Daniel R. Hopgood | Executive Vice President & Chief Financial Officer | $1.0M | 1973 |
| Jennifer L. McDonough | Executive Vice President, General Counsel & Corporate Secretary | $850,843 | 1972 |
| Justin Hall | Executive Vice President of Medical and Fluid Solutions | $780,409 | 1979 |
| Katie Colacarro | Vice President of Corporate Development | — | — |
| Lara L. Mahoney | Vice President of Investor Relations & Corporate Communications | — | — |
| Matthew Matejka | Senior Director of Investor Relations | — | — |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Sundaram Nagarajan President and Chief Executive Officer | 2025 | $1.0M | $3.5M | $1.3M | $8.2M |
| Joseph Kelley Executive Vice President | 2025 | $579,738 | $991,980 | $409,063 | $2.7M |
| Stephen Lovass Former Executive Vice President | 2025 | $323,705 | $481,835 | $246,534 | $2.2M |
| Daniel Hopgood Executive Vice President and Chief Financial Officer | 2025 | $549,539 | $850,184 | $417,100 | $2.2M |
| Srinivas Subramanian Executive Vice President | 2025 | $469,692 | $634,927 | $393,555 | $2.0M |
| Jennifer McDonough Executive Vice President | 2025 | $479,723 | $720,094 | $339,836 | $1.8M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-09-10 | $0.94 | 2026-10-02 |
| 2026-06-18 | $0.82 | 2026-07-06 |
| 2026-03-19 | $0.82 | 2026-04-03 |
| 2025-12-17 | $0.82 | 2026-01-02 |
| 2025-09-11 | $0.82 | 2025-09-25 |
| 2025-06-18 | $0.78 | 2025-07-03 |
| 2025-03-20 | $0.78 | 2025-04-03 |
| 2025-01-02 | $0.78 | 2025-01-16 |